SDC2 and malignant colon neoplasm: Treatment with exogenously shed syndecan-2 from HT29-cell-conditioned media enhanced the migration of HCT116 cells (Figure 2D), suggesting that shed syndecan-2 may also regulate the tumorigenic characteristics of colon cancer cells in a paracrine manner.